Roger V Ortines Selected Research

Roger V Ortines Research Topics

Disease

11	Infections 10/2022 - 01/2017
5	Inflammation (Inflammations) 01/2022 - 03/2009
2	Staphylococcal Infections 10/2022 - 01/2018
2	Dysbiosis 01/2022 - 01/2019
2	Osteomyelitis 01/2020 - 01/2017
2	Infectious Arthritis (Septic Arthritis) 01/2020 - 01/2017
1	Wound Infection (Wound Infections) 10/2022
1	Bacteremia 10/2022
1	Abscess 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Dermatitis 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Allergic Rhinitis 01/2021
1	Coinfection 11/2019
1	Surgical Wound Infection 01/2019
1	Persistent Infection 01/2018
1	Hypertrophy 03/2009
1	Heart Failure 03/2009
1	Fibrosis (Cirrhosis) 03/2009
1	Hypertension (High Blood Pressure) 07/2008
1	Hypoxia (Hypoxemia) 07/2008

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2017
3	CytokinesIBA 01/2021 - 03/2009
3	Monoclonal AntibodiesIBA 01/2019 - 01/2017
2	Linezolid (Zyvox)FDA Link 10/2022 - 04/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 11/2017
2	TitaniumIBA 01/2018 - 01/2017
1	Oxazolidinones (2 Oxazolidone)IBA 10/2022
1	PlacebosIBA 10/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	DefensinsIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	interleukin-21 (interleukin 21)IBA 01/2022
1	butyl phosphorotrithioate (DEF)IBA 01/2022
1	tofacitinibIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	quinolineIBA 01/2021
1	quinoline-val-asp(OMe)-CH2-OPHIBA 01/2021
1	AllergensIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	KetonesIBA 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	CaspasesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	LuciferasesIBA 11/2019
1	Filaggrin ProteinsIBA 01/2019
1	Antimicrobial Cationic PeptidesIBA 01/2019
1	Interleukin-33IBA 11/2017
1	Interleukin-18 (Interleukin 18)IBA 11/2017
1	Virulence Factors (Pathogenicity Factors)IBA 11/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	factor AIBA 01/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2009
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2009
1	p38 Mitogen-Activated Protein KinasesIBA 03/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2009
1	Tumor Necrosis Factor InhibitorsIBA 03/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2008

Therapy/Procedure

1	Immunotherapy 01/2021
1	Prostheses and Implants (Prosthesis) 01/2018